Pharmacovigilance is a public health activity focus on the identification, assessment and prevention of adverse reactions for marketed drugs. An Adverse Reaction is defined as any undesirable effect which appears after the administration of a drug.
In order to achieve this goal, a close collaboration is required among the different parts involved in the use of the medicine (pharmaceutical companies, health professionals, health authorities and patients). In this way, and faithful to our commitment for improving health and quality of life of patients and ensure their safety, CHEMO (Chemo Ibérica SA, Laboratorios Farmalán SA, Laboratorios León Farma SA, Laboratorios Liconsa SA, Universal Farma SL), EXELTIS, MABXIENCE in compliance with current legislation, provides a system for reporting Adverse Drug Reactions, in order to ensure drug safety and to inform to the relevant health authorities and take appropriate measures.
Pursuant to the provisions of Law 3/2018, of December the 5. Protection of Personal Data and Guarantee of Digital Right (LOPDGDD), Laboratorios Liconsa, S.A. informs you that your personal data provided by you will form part of the file PHARMACOVIGILANCE which the company is responsible. These personal data are collected and stored in order to comply with legal requirements on reporting adverse human and veterinary drug reactions. You could exercise your rights of access, rectification, cancellation and opposition to the processing of data through written communication to the following address: Ebrosa Buildin, Manuel Pombo Angulo, 28 3th floor 28050 Madrid, Spain.